Online Exclusive Article

The Relationship Between Symptom Severity and Symptom Interference, Education, Age, Marital Status, and Type of Chemotherapy Treatment in Israeli Women With Early-Stage Breast Cancer

Ayelet Prigozin

Beatrice Uziely

Catherine F. Musgrave

symptom assessment, education, breast neoplasms
ONF 2010, 37(6), E411-E418. DOI: 10.1188/10.ONF.E411-E418

Purpose/Objectives: To examine symptom severity's relationship to symptom interference, education, age, marital status, and type of chemotherapy treatment in Israeli women with stage I or II breast cancer.

Design: Cross-sectional, descriptive, correlational design.

Setting: Hadassah University Hospital's oncology daytime care unit in Israel.

Sample: 51 women with stage I or II breast cancer who were receiving an adjuvant chemotherapy protocol that included doxorubicin.

Methods: Women receiving adjuvant chemotherapy were given the M.D. Anderson Symptom Inventory (MDASI), a modified version of the Breast Cancer Prevention Trial Hot Flashes Subscale (BCPT-HFS), and a demographic and treatment questionnaire to assess their symptoms toward the end of their chemotherapy treatment.

Main Research Variables: Symptom severity, symptom interference, education, age, marital status, and type of chemotherapy treatment.

Findings: The most frequent and severe symptoms were fatigue, sleep disturbance, and drowsiness. The MDASI symptom severity total scores were positively correlated with total scores of interference with activities of daily life, with most individual symptoms being significantly related to the total interference scores. The strongest relationships were found with fatigue, distress, and sadness. Education was inversely related to the MDASI general symptom severity total scores; age was inversely related to the BCPT-HFS total scores. Patients who received treatment with doxorubicin plus cyclophosphamide or doxorubicin, cyclophosphamide, plus fluorouracil had greater symptom severity than those who received doxorubicin plus cyclophosphamide followed by paclitaxel and had their symptoms evaluated after receiving paclitaxel.

Conclusions: Increased symptom severity disrupts daily function and life in women with breast cancer.

Implications for Nursing: Evidence-based symptom profiles for different chemotherapy protocols are needed.

Jump to a section


    Armstrong, T. S. (2003). Symptoms experience: A concept analysis. Oncology Nursing Forum, 30, 601-606.
    Boehmke, M. M. (2004). Measurement of symptom distress in women with early-stage breast cancer. Cancer Nursing, 27, 144-152.
    Boehmke, M. M., & Dickerson, S. S. (2005). Symptom, symptom experiences, and symptom distress encountered by women with breast cancer undergoing current treatment modalities. Cancer Nursing, 28, 382-389.
    Bottomley, A., Biganzoli, L., Cufer, T., Coleman, R. E., Coens, C., Efficace, F., … Piccart, M. (2004). Randomized, controlled trial investigating short-term health-related quality of life with doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in patients with metastatic breast cancer. Journal of Clinical Oncology, 22, 2576-2586.
    Byar, K. L., Berger, A. M., Bakken, S. L., & Cetak, M. A. (2006). Impact of adjuvant breast cancer chemotherapy on fatigue, other symptoms, and quality of life [Online exclusive]. Oncology Nursing Forum, 33, E18 E26.
    Cleeland, C. S. (2007). Symptom burden: Multiple symptoms and their impact as patient-reported outcomes. Journal of the National Cancer Institute. Monographs, 37, 16-21.
    Cleeland, C. S., Mendoza, T. R., Wang, X. S., Chou, C., Harle, M. T., Morrissey, M., & Engstrom, M. C. (2000). Assessing symptom distress in cancer patients. Cancer, 89, 1634-1646.
    Israeli National Cancer Registry. (2010). Cancer incidence tables of 2007 Updated 2010. Retrieved from
    Ivanova, M. O., Ionova, T. I., Kalyadina, S. A., Uspenskaya, O. S., Kishtovich, A. V., Guo, H., … Wang, X. S. (2005). Cancer-related symptom assessment in Russia: Validation and utility of the Russian M. D. Anderson Symptom Inventory. Journal of Pain and Symptom Management, 30, 443-453.
    Jim, H. S., Andrykowski, M. A., Munster, P. N., & Jacobsen, P. B. (2007). Physical symptoms/side effects during breast cancer treatment predict posttreatment distress. Annals of Behavioral Medicine, 34, 200-208.
    Kirkova, J., Davis, M. P., Walsh, D., Tiernan, E., O'Leary, N., LeGrand, S. B., … Russell, K. M. (2006). Cancer symptom assessment instruments: A systematic review. Journal of Clinical Oncology, 24, 1459-1473.
    Lee, B., Dantzer, R., Langley, K. E., Bannett, G. J., Dougherty, P. M., Dunn, A. J., … Cleeland, C. S. (2004). A cytokine-based neuroimmunologic mechanism of cancer-related symptoms. Neuroimmunomodulation, 11, 279-292.
    Manning-Walsh, J. K. (2005). Psychospiritual well-being and symptom distress in women with breast cancer [Online exclusive]. Oncology Nursing Forum, 32, E56 E62.
    Mannor, B., & Zohar, C. (2006). Sexual functioning and information needs in women with premature menopause following breast cancer treatment [In Hebrew]. Harefuah, 145, 90-94.
    Mystakidou, K., Cleeland, C. S., Tsilika, E., Katsouda, E., Primikiri, A., Parpa, E., … Mendoza, T. (2004). Greek MD Anderson Symptom Inventory: Validation and utility in cancer patients. Oncology, 67, 203-210.
    Okuyama, T., Wang, X. S., Akechi, T., Mendoza, T. R., Hosaka, T., Cleeland, C. S., & Uchitomi, Y. (2003). Japanese version of the MD Anderson Symptom Inventory: A validation study. Journal of Pain and Symptom Management, 26, 1093-1104.
    Polit, D. F., & Beck, C. T. (2008). Nursing research: Generating and assessing evidence for nursing practice (8th ed.). Philadelphia, PA: Lippincott Williams and Wilkins.
    Schultz, P. N., Klein, M. J., Beck, M. L., Stava, C. & Sellin, R. V. (2005). Breast cancer: Relationship between menopausal symptoms, physiologic health effects of cancer treatment and physical constraints on quality of life in long-term survivors. Journal of Clinical Nursing, 14, 204-211.
    Stanton, A. L., Bernaards, C. A., & Ganz, P. A. (2005). The BCPT symptom scales: A measure of physical symptoms for women diagnosed with or at risk for breast cancer. Journal of the National Cancer Institute, 97, 448-456.
    Wang, X. S., Fairclough, D. L., Liao, Z., Komaki, R., Chang, J. Y., Mobley, G. M., & Cleeland, C. S. (2006). Longitudinal study of the relationship between chemoradiation therapy for non-small-cell lung cancer and patient symptoms. Journal of Clinical Oncology, 24, 4485-4491.
    Wang, X. S., Laudico, A. V., Guo, H., Mendoza, T. R., Matsuda, M. L., Yosuico, V. D., … Cleeland, C. S. (2006). Filipino version of the M. D. Anderson Symptom Inventory: Validation and multisymptom measurement in cancer patients. Journal of Pain and Symptom Management, 31, 542-552.
    Wang, X. S., Wang, Y., Guo, H., Mendoza, T. R., Hao, X. S., & Cleeland, C. S. (2004). Chinese version of the M. D. Anderson Symptom Inventory: Validation and application of symptom measurement in cancer patients. Cancer, 101, 1890-1901.
    Yun, Y. H., Mendoza, T. R., Kang, I. O., You, C. H., Roh, J. W., Lee, C. G., … Wang, X. S. (2006). Validation study of the Korean version of the M. D. Anderson Symptom Inventory. Journal of Pain and Symptom Management, 31, 345-352.